SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-033391
Filing Date
2021-06-17
Accepted
2021-06-17 17:07:57
Documents
12
Period of Report
2021-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mnov-8k_20210616.htm   iXBRL 8-K 59308
  Complete submission text file 0001564590-21-033391.txt   189566

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210616.xsd EX-101.SCH 5784
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210616_lab.xml EX-101.LAB 19470
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210616_pre.xml EX-101.PRE 11636
5 EXTRACTED XBRL INSTANCE DOCUMENT mnov-8k_20210616_htm.xml XML 3563
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 211025664
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences